Magdy Selim, MD, PhD is Professor of Neurology at Harvard Medical School. He serve as the Chief of the Division of Stroke and Cerebrovascular Disease and the Director of the Comprehensive Stroke Center at Beth Israel Deaconess Medical Center (BIDMC) in Boston. Dr. Selim graduated from the University of Alexandria – Faculty of Medicine in Egypt. He completed his residency training at the University of Massachusetts Medical Center and fellowship training at BIDMC.
Dr. Selim maintains extensive academic, educational, clinical and research activities across a broad range of neurological- and stroke-related topics. He is a fellow of the American Neurological Association, the American Heart Association/ American Stroke Association Stroke Council, and the European Stroke Organization. He is also a member of the FDA Neurological Devices Advisory Panel since 2018. Dr. Selim has been one of Castle Connolly, Inc. America’s and Boston’s Top Doctors since 2007. He has published more than 300 original papers, books, and book chapters.
Dr. Selim has received funding from the NINDS, NIA and AHA, and has led several NIH-funded, multi-center, international clinical trials. Dr. Selim is particularly known for his interest and research in intracerebral hemorrhage. He is the founder of the HEmorrhagic stroke Academia inDuStry (HEADS) roundtable; a think tank group comprised of leading researchers and physicians in the field, industry representatives, and decision-makers from regulatory agencies such as NINDS and FDA, aiming to improve ICH research and develop a roadmap to expedite the development of new therapies. He also played a key role in the establishment of the World Intracranial Hemorrhage (WICH) Organization.